June 05, 2015
End-payor plaintiffs accusing Takeda Pharmaceutical Co. and other drugmakers of participating in a pay-for-delay scheme over diabetes drug Actos told a New York federal court Thursday that a recent California Supreme Court ruling in another pay-for-delay case bolsters their argument against the dismissal of their allegations.
May 20, 2015
The plaintiffs accusing Takeda Pharmaceutical Co. and other drugmakers of participating in a pay-for-delay scheme for the Actos diabetes drug argued Tuesday in New York federal court that a recent high-profile ruling against the Federal Trade Commission in a similar filing should not have any bearing on the case.
May 13, 2015
Takeda Pharmaceutical Co. Ltd. and several generic-drug makers accused of delaying cheaper versions of diabetes treatment Actos on Tuesday said the recent dismissal of a chunk of one of the Federal Trade Commission's own pay-for-delay cases has doomed the Actos antitrust litigation.